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Introduction:
Background
Patients with difficult intravenous access (DIVA) present an ongoing challenge to providing
emergency care and resuscitation. Of the 116.8 million ED visits in 2007 in the United States 27%
required IV catheter placement.1 In many cases, failure to obtain peripheral IV access necessitates
central venous cannulation (CVC), which introduces an increased risk of immediate and delayed
complications secondary to a more invasive procedure and incurs increased utilization of departmental
resources.2 Extrajugular vein cannulation is an alternative approach but is obtainable in less than 50%
of patients and usually necessitates the involvement of a physician.3 This approach also usually
requires the patient to tolerate supine or Trendelenburg positioning, which may be difficult for many
patients.
Bedside ultrasound provides an alternative method of obtaining venous access when traditional
landmark methods fail.4,5 However, ultrasound-guided peripheral IVs (USGPIVs) suffer from a failure
rate of up to 8% in the first hour after placement and 47% within the first 24 hours after placement.4,6,7
This is much higher than traditionally placed IVs, which have reported failure rates of only 6-32% after
three days.8,9 Dislodgement of an IV has the potential to threaten patient safety by interrupting delivery
of medications and fluids and putting patients at risk of extravasation that can lead to ischemia and/or
tissue necrosis.
There are limited data regarding the reasons for the higher rate of failure for IVs placed under
ultrasound guidance. One possible explanation is ultrasound provides the ability to access vessels that
are deeper and smaller than those visible or palpable on physical exam. In addition, USGPIVs are often
placed in different locations. In one study comparing the two techniques, 74% of USGPIVs were
3placed in the basilic or brachial vein; whereas 86% of traditionally placed IVs were placed in the
forearm, hand, or antecubital fossa.10 Catheters that have to traverse through more subcutaneous tissue
or are in atypical locations may be more likely to kink or dislodge suggesting the hypothesis that IV
durability is affected by the characteristics of the vessel being cannulated. By analyzing the outcomes
of IVs placed under ultrasound guidance, the current study set out to determine the influence of vessel
depth, diameter, and location on IV longevity.
Methods:
Study Design
This study utilized a previously gathered database of DIVA patients who underwent USGPIV
placement in the ED. This database was gathered prospectively and included images and measurements
of the target vessel’s depth, diameter, and location. The original analysis of this USGPIV database
examined the relation between vessel depth and diameter on success of USGPIV placement and has
been reported in the literature.11 For the current study an additional retrospective chart review was
performed on patients in the database to determine the outcome and survival time of the USGPIVs. The
institution internal review board approved the study and written informed consent was obtained for all
patients.
Study Setting and Population
Patients in this database were included in the current study if they had DIVA (defined as any
patient with two failed peripheral IV attempts or a history of DIVA with the inability to visualize or
palpate veins on physical exam) and underwent successful USGPIV placement by one of four study
sonographers from December 2007 to May 2008. The setting was an urban tertiary care university ED
with a 4-year emergency medicine (EM) residency program and an emergency ultrasound fellowship.
All EM residents complete a four-week ultrasound course during the PGY-2 year during which the
requirements for emergency ultrasound, as recommended by the American College of Physicians 2001
4guidelines, are met.12 The USGPIVs were placed by two PGY-2 residents, one PGY-3 resident and an
ultrasound fellow all of whom had met the above ACEP guidelines as well as demonstrating successful
placement of at least 10 USGPIVs.
Study Protocol
Patients in the database underwent USGPIV placement with the following protocol. A
tourniquet was applied to the upper extremity, which was then scanned for a target vessel using a
Sonosite Micromaxx (Sonosite Inc., Bothell, WA) with a high-frequency L38⁄13-6MHz linear array 
transducer. Upon identification of a target vessel the sonologist obtained a transverse image of the
vessel with measurement of the vessel depth (distance from the skin surface to the near wall of vessel)
and diameter (distance from middle of near wall to middle of far wall). The location of the vessel was
documented on a diagram of the upper extremity. Sterilization of the overlying skin was standardized
with chlorhexidine swab and use of a sterile sheath. Only 20 gauge 48 mm long (Angiocath Autoguard,
BD Medical Systems, Sandy, UT) catheters were used for USGPIV placement.
The sonologist attempted to place the catheter using the single-operator technique visualizing
the needle enter the vein using real-time dynamic scanning. The use of transverse and/or longitudinal
plane was based on sonologist preference. Successful IV placement was defined as aspiration of 5ml of
blood and the ability to flush the line without resistance. The depth, diameter, and location of all
USGPIV attempts were recorded. In addition, background demographic, historical, and physical
examination information was recorded for each patient.
The final outcome of each USGPIV was determined by a retrospective chart review. Patients
were excluded if an USGPIV was unable to be established as per the above protocol or if lack of
charting documentation prevented an accurate estimation of IV removal. In the study institution a
dedicated IV tracking form is utilized to document the status of all peripheral IVs on a continuous
basis. Hospital policy mandates thrice-daily evaluation and documentation on this form of each IV
access point on every patient, a record of the time of, and reasons for, IV removal, and any associated
5complications. Two blinded independent study personnel reviewed all charts and the time and reason
for IV removal was extracted from the IV tracking forms. If there was a disagreement between the two
reviewers on the time of IV removal or on the reason for IV removal, a third reviewer examined the
chart. Patients were excluded if there was a failure of a consensus of at least 2 of the 3 reviewers on the
time or outcome of the IV. The reviewers followed the successfully placed USGPIVs for 48 hours or up
to the point of IV removal, whichever came first. Failures were considered IVs that infiltrated,
dislodged, stopped working, or were discontinued prematurely for any reason. IVs that were removed
for routine reasons such as lack of a need for ongoing IV access or patient discharge were not counted
as failures.
Statistical Analysis
Descriptive statistics were performed on patient characteristics for patients with failed vs. non-
failed USGPIVs. Dichotomous data are presented as percentages. Continuous variables were
categorized into logical groups for analysis. Vessel depth was divided into three zones: shallow
(<0.4cm), intermediate (0.4cm-1.19cm), and deep (≥1.2cm). IV diameter was divided into four groups
(<0.3cm, 0.3-0.39cm, 0.4-0.49cm, and ≥0.5cm). Vessel location was divided into proximal (brachial
region) and distal (antecubital fossa, forearm, or hand veins). The Fisher exact test and χ2 test were
used for comparisons of categorical variables, as appropriate. Follow-up began at the time and date of
successful USGPIV placement and ended at the time and date of documented USGPIV failure or
removal. In order to account for patient censoring (IVs that were removed for routine reasons such as
patient discharge prior to the end of the 48 hour follow-up period) USGPIV longevity was analyzed
using a Kaplan-Meier survival algorithm. Sample size was determined using the Log-Rank Freedman
method to compare two survival functions. Based on previous data 50-60% of USGPIVs fail at 48
hours. At least 92 patients were required to detect a 15% difference in survival for a given covariate
assuming an alpha of 0.05 and a power of 0.80.
Univariate analysis was performed on vessel characteristics (depth, diameter, and location)
6using the log-rank test of equality. Significant predictors in the univariate analysis (p value of <0.05)
were included in a Cox proportional hazard regression analysis. This multivariate model checked for
possible interactions between variables. Proportionality of the model was checked by visual inspection
of the graphed Schoenfield residuals and goodness of fit was checked using Cox-Snell residuals. Stata
11 was used for the analysis (StataCorp, College Station, TX).
Results:
There were 183 patients in the database of which 18 patients were excluded for failure to
successfully establish an USGPIV and 14 patients were excluded due to lack of sufficient
documentation (12) or reviewer disagreement on IV outcome (2), yielding a total of 151 patients for
analysis. The mean age of the patients was 53 years (SD ± 18 years). Ninety-six (64%) patients were
female and 115 (76.7%) were African American. 22 USGPIVs (15%) were placed in shallow (<0.4cm)
vessels, 106 (70%) were placed in intermediate vessels (0.4-1.19cm), and 23 (15%) were placed in
deep vessels (≥1.2cm). There were 22 USGPIVs (15%) placed in vessels with a diameter < 3mm, 55
USGPIVs (36%) placed in vessels 3-3.9mm, 46 USGPIVs (30%) placed in vessels 4-4.9mm, and 28
USGPIVs (19%) placed in vessels ≥5mm. There were 95 USGPIVs (63%) placed proximally in the
brachial region and 56 (37%) placed distally in the antecubital fossa or forearm veins. No USGPIVs
were placed in the wrist or hand.
After 48 hours, 48 USGPIVs (32%) had failed due to IV infiltration, dislodgement, or patient
discomfort. Thirty-six USGPIVs (24%) had been removed for routine reasons, such as patient
discharge or no further need for intravenous access, and the remaining 67 USGPIVs (44%) were still in
place and without incident. Of the 48 USGPIV failures 20 IVs (42%) infiltrated, 11 (23%) dislodged,
16 (33%) were not flushing, and 1 IV (2%) was removed due to patient discomfort. There were no
significant differences in the patient characteristics of IVs that failed vs. IVs that did not fail within 48
hours (table 1).
Survival Analysis
7The Kaplan-Meier survival analysis yielded an USGPIV survival probability of 0.63 (95%CI
0.53-0.70, Figure 1) at 48 hours. Analysis of vessel characteristics using the log-rank test for equality
revealed vessel depth, location, and diameter each potentially had a significant association with IV
longevity. When placed in the Cox multivariate regression model and checking for interactions between
variables both vessel depth and location were found to each be independently and significantly
associated with USGPIV longevity, however vessel diameter was not.
Vessel Depth
USGPIV survival probability was excellent (1.00) for shallow vessels (<0.4cm, n=22), moderate
(0.62, 95% CI 0.51-0.71) for intermediate vessels (0.41-1.19cm, n=106), and poor (0.29, 95% CI 0.11-
51) for deep vessels (≥1.2cm, n=23), p < 0.0001. Shallow and deep survival curves became
significantly different as early as 3 hours after placement and all three zones were significantly
different from each other from 12 hours onwards (figure 2a, Table 2).
Vessel Location
USGPIV placement in the antecubital fossa or forearm was associated with improved survival
probability when compared to more proximal placement in the region of the brachial or basillic veins
(figure 2b, Table 2). The survival curves for vessel location became significantly different at 18 hours
with a survival probability of 0.93 (95%CI 0.82-0.97) for distal vessels versus 0.71 (95%CI 0.60-0.80)
for proximal vessels.
Multivariate Model
In the Cox regression analysis depth and location were each independently associated with IV
longevity. For each increase of 0.2cm in vessel depth the odds of an IV failing within 48 hours
increases by a hazard ratio of 1.36 [1.15-1.61]. Placement of an IV in the brachial region versus the
forearm or antecubital fossa increases the likelihood of failure by a hazard ratio of 2.76 [1.25-6.09].
The multivariable model satisfied criteria for proportionality and Cox-Snell residuals did not suggest a
lack of goodness of fit for the model (p = 0.17). Utilizing these hazard ratios allows us to create a
8model to predict the survival curve for a given vessel depth and location. Examples of predicted
survival curves for various permutations of vessel depth and location using this model are demonstrated
(figure 3).
Discussion:
The aim of this study was to determine the effect of vessel parameters on the survival of
USGPIVs. While longevity of USGPIVs has been evaluated in other studies this is the first study to
examine the relationship of vessel characteristics and USGPIV survival.7 The study found that vessel
depth and location were both predictive of early failure of USGPIVs. The vessel characteristic that was
most strongly associated with failure was depth from skin surface and this effect seemed to occur more
rapidly when compared to other vessel characteristics. As early as three hours USGPIVs placed in
shallow vessels (< 0.4cm) had significantly better survival than those placed in deep vessels (≥1.2cm).
By 12 hours over half of USGPIVs in deep vessels fail. Vessel location had a delayed but also
independently significant effect on IV survival. Within 18 hours of placement, USGPIVs placed in the
antecubital fossa or forearm had better survival compared with those placed in the brachial or basillic
veins.
Two studies have shown that successful USGPIV placement is influenced by vessel diameter and
depth.11,13 The current study shows that after successful cannulation the continued survival of the IV is
also influenced by depth, and, in addition, by IV location. Vessel diameter did not affect catheter
survival after successful placement. Ideally, the sonologist would be able to select the vein with the
greatest likelihood of both successful placement and longevity from a number of possible choices.
However, when the choice is limited, as is often the case in patients with DIVA, knowledge of these
relationships can aid the sonographer in choosing the optimal vessel for success and durability. When
no suitable vessels exist the sonographer can opt to select a different method of IV access (midline
catheter, intraosseus line, or CVC) and not subject the patient to unnecessary IV sticks. In the case
9where an IV is needed for only a brief period, depth should be the main consideration. When using a
48mm catheter, vessels ≥ 1.2cm should be avoided altogether since they have a high immediate failure
rate. When an IV is needed for a longer period (≥18 hours), the sonographer should additionally
consider the importance of vessel location attempting to avoid vessels in the brachial region.
To our knowledge there are no studies specifically investigating the basis of the association
between deeper and proximal veins and poor IV survival; although the finding is unlikely to surprise
emergency physicians familiar with the challenges of maintaining IV access in this patient population.
With deeper vessels a shorter portion of catheter tip ends up in the vessel and is more easily dislodged.
In addition, with a constant catheter length, deeper vessels require inserting the catheter at a steeper
angle. This has several theoretical adverse consequences. First, it makes it increasingly likely that the
tip of the introducer needle pierces the back wall of the vessel prior to full introduction of the plastic
catheter, resulting in damage to the vessel (predisposing to both leakage and thrombosis). Second, if the
back wall of the vessel is not punctured, there is an increased risk of the catheter tip getting caught up
on it or traumatizing the endothelium as it is advanced. Third, the sharp angle between the
subcutaneous path of the catheter and the vessel often results in kinking when it changes its direction to
conform to the vessel. This severely limits flow of intravenous fluids as well as being another potential
source of trauma and/or thrombosis in the vessel.
With respect to location, the subcutaneous fat of the arm is often thicker and looser than that in
the antecubital fossa or forearm.14 This makes it incrementally vulnerable to failure, both due to the
reasons discussed above, and also due to the instability, mobility, and mass of the surrounding loose
adipose tissue. This may be exacerbated by the tendency to compress the subcutaneous tissue to
facilitate cannulation. When these tissues are released and re-expand after successful placement of the
USGPIV, there is distortion of the catheter track with the potential for dislodgement or kinking. The
mobility of the shoulder joint, as well as the location of the basilic and brachial veins on the medial side
of the arm may also render these sites at greater risk of mechanical dislodgement. The only study to
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cast light on this issue, the one by Mills et al., supports the notion that short catheter length may be a
cardinal flaw in deeper vessels.6 In that study a standard length catheter was used to cannulate the vein,
but this was immediately followed by placement of a 15 cm long catheter over a guide wire. The only
catheter of 24 subsequently to fail (median duration of catheter survival 26 hours) did so after 15
minutes. This study used proximal veins exclusively, making these findings particularly striking
compared to ours in which 66% of patients in this group had lost their IVs within 24 hours. Notably
the findings of Dargin et al., using a 63.5mm catheter, were very similar to ours.7 Further studies are
needed to identify the minimal length and optimal catheter type for improved IV longevity in these
deeper peripheral veins.
Limitations
Potential bias may have occurred as a result of the outcome variable (IV longevity) being
obtained by retrospective chart review. The reliability of this outcome is contingent on rapid realization
of IV failure and clear documentation of the event by hospital personnel. While there were some charts
that lacked clear documentation of IV outcome (12/183), there was little disagreement between the two
reviewers (2/183). Furthermore, in spite of the strict hospital policies regarding documentation about
IV access sites, it is possible that failed catheters were documented as “removed” either because they
were no longer needed, or another was easily obtained, or to avoid the appearance of an adverse event.
In addition, it is in the nature of an intravenous failure that it can only be detected after it has occurred,
and IV failures are rarely detected immediately. All these factors would lead to bias towards the
appearance of artifactually increased longevity. Stated more simply: our study necessarily
underestimated the failure rate of the USGPIVs.
Some factors that may have affected the lifespan of the IVs were not collected. These include the
nature of the infusions running through the IV, how often the IV was accessed, movement of the
extremity, or whether any fixation device such as an arm-board was utilized. Additionally, there was no
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standardization to the method for which the IV was secured. In our institution peripheral IVs are
routinely secured by use of a Tegaderm™ and other commercially available fixation devices such as
arm boards are rarely used. It is possible that USGPIV longevity could be improved by post-procedural
methods, however this was not assessed in this study.
The generalizability of the study may be limited since this was a single-center study, and with a
relatively small cohort of sonologists obtaining data, it is likely that their skills with USGPIV
cannulation are superior to the average among emergency physicians. However the one-hour 10% early
IV failure rate seen in our study is similar to failure rates documented in other studies. 4,7 The early
USGPIV failure depth of 1.2cm found in our study was based on using a catheter length of 48mm. As
noted above, it is likely that altering either the catheter length or the angle of approach would affect the
depths at which USGPIV longevity is compromised. In addition, only one catheter gauge was used (20-
gauge). This variable was controlled in the database in order to assess the relationship of other
variables on USGPIV success rates. Interestingly, a study by Catney et al found that 18 gauge IVs were
more durable than 20 or 22 gauge IVs suggesting that larger diameter thicker catheters may be less
susceptible IV kinking and failure. 8 Logically, this finding would be true for USGPIVs, however this
was not assessed in the current study.
A question still remains as to whether ultrasound guidance is itself responsible for the short
survival of these lines or whether this is due to some other factor (e.g. relatively short catheter length,
the instability of thick subcutaneous adipose tissue, or greater friability of deeper veins). Since IV
access using landmark techniques (often in the basilic region) has been performed for decades it seems
likely that deeper veins accessed by any method would have an equally poor prognosis. To determine
whether this is actually so will require further study.
Conclusion:
Ultrasound provides a useful rescue method for establishing intravenous access in patients with
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DIVA. The current study reveals two factors that significantly affect the durability of these IVs – depth
and location. Using a 48mm catheter, vessels ≥ 1.2cm deep have a high likelihood of USGPIV failure
and should only be cannulated when other options are not available. Vessels < 0.4cm deep yield the
best USGPIV longevity. Forearm and antecubital sites are more enduring than those in the upper arm.
Understanding of these associations will help the sonologist select the optimal vessel for successful
USGPIV cannulation and longevity.
References:
1. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency
department summary. National health statistics reports. 2010;(26):1-31.
2. McGee DC, Gould MK. Preventing complications of central venous catheterization. The New
England journal of medicine. 2003;348(12):1123-33.
3. Costantino TG, Kirtz JF, Satz WA. Ultrasound-Guided Peripheral Venous Access vs. the External
Jugular Vein as the Initial Approach to the Patient with Difficult Vascular Access. The Journal of
emergency medicine. 2010;39(4):462-7.
4. Keyes LE, Frazee BW, Snoey ER, Simon BC, Christy D. Ultrasound-guided brachial and basilic
vein cannulation in emergency department patients with difficult intravenous access. Annals of
emergency medicine. 1999;34(6):711-4.
5. Costantino TG, Parikh AK, Satz WA, Fojtik JP. Ultrasonography-guided peripheral intravenous
access versus traditional approaches in patients with difficult intravenous access. Annals of emergency
medicine. 2005;46(5):456-61.
6. Mills CN, Liebmann O, Stone MB, Frazee BW. Ultrasonographically guided insertion of a 15-cm
catheter into the deep brachial or basilic vein in patients with difficult intravenous access. Annals of
emergency medicine. 2007;50(1):68-72.
7. Dargin JM, Rebholz CM, Lowenstein RA, Mitchell PM, Feldman JA. Ultrasonography-guided
peripheral intravenous catheter survival in ED patients with difficult access. The American journal of
emergency medicine. 2010;28(1):1-7.
8. Catney MR, Hillis S, Wakefield B, et al. Relationship between peripheral intravenous catheter Dwell
time and the development of phlebitis and infiltration. Journal of infusion nursing : the official
publication of the Infusion Nurses Society. 24(5):332-41.
9. Bregenzer T, Conen D, Sakmann P, Widmer a F. Is routine replacement of peripheral intravenous
catheters necessary? Archives of internal medicine. 1998;158(2):151-6.
10. Bauman M, Braude D, Crandall C. Ultrasound-guidance vs. standard technique in difficult vascular
access patients by ED technicians. The American journal of emergency medicine. 2009;27(2):135-40.
11. Panebianco NL, Fredette JM, Szyld D, et al. What you see (sonographically) is what you get: vein
and patient characteristics associated with successful ultrasound-guided peripheral intravenous
placement in patients with difficult access. Academic emergency medicine : official journal of the
Society for Academic Emergency Medicine. 2009;16(12):1298-303.
12. Anon. American College of Emergency Physicians Emergency Ultrasound Guidelines. Annals of
Emergency Medicine. 2001;38(4):470-81.
13
13. Witting MD, Schenkel SM, Lawner BJ, Euerle BD. Effects of vein width and depth on ultrasound-
guided peripheral intravenous success rates. The Journal of emergency medicine. 2010;39(1):70-5.
14. Botte MJ, Gelberman RH. Acute compartment syndrome of the forearm. Hand clinics.
1998;14(3):391-403.
